Clinical trial
Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of…
NCT00033137 · National Cancer Institute (NCI), NIH · Recruiting
Key facts
| NCT number | NCT00033137 |
|---|---|
| Title | Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer |
| Official title | Birt-Hogg-Dub(SqrRoot)(Copyright) Syndrome: Characterization of the FLCN Disease Gene and Predisposition to Renal Cancer, Cutaneous Fibrofolliculoma and Pulmonary Cysts |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Recruiting |
| Study type | Observational |
| Conditions | Kidney Neoplasms, Kidney Cancer, Pneumothorax, FLCN Protein, Human |
| Enrollment | 950 |
| Start date | May 13, 2002 |
| First posted | Apr 8, 2002 |
| Last update posted | Feb 5, 2026 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: